Siron Clinical
Siron Clinical is a Netherlands-based CRO specializing in complex clinical trials for orphan, pediatric, and medical device programs. It serves small and medium-sized biotech sponsors across Europe with customizable FSP and full-service models, and is now part of WEP Clinical following its January 2026 acquisition.
- Company typePrivate
- Founded2000
- HeadquartersRoosendaal, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingServices
Siron Clinical firmographics
Firmographics- Name
- Siron Clinical
- Legal name
- Siron Clinical
- Website
- https://sironclinical.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Siron Clinical is a Netherlands-based CRO specializing in complex clinical trials for orphan, pediatric, and medical device programs. It serves small and medium-sized biotech sponsors across Europe with customizable FSP and full-service models, and is now part of WEP Clinical following its January 2026 acquisition.
- Ownership category
- akta.pro rank
Siron Clinical industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Siron Clinical is headquartered
LocationHeadquarters
- HQ city
- Roosendaal
- HQ country
- Netherlands
- HQ region
- Europe
Offices3 records
Markets served
Siron Clinical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- CRO Services – FSP Engagements: Siron Clinical provides specialized Functional Service Provider engagements where sponsors engage the company for specific tasks and functions (clinical monitoring, regulatory submissions, project management, data management) at every stage of clinical trials. Revenue is generated through service contracts with biotech and pharma sponsors.
- CRO Services – Full-Service Contracts: Full-service CRO contracts providing end-to-end clinical trial management from Phase I through Phase IV, covering project management, clinical monitoring, quality assurance, regulatory submissions, and additional services for biotech companies navigating European clinical research.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Siron Clinical product offering
Product offeringCore offering
Siron Clinical is an international contract research organization (CRO) that provides clinical trial services to biotech and biopharma sponsors, including customizable Functional Service Provider (FSP) engagements and full-service CRO contracts. Core offerings cover project management, clinical monitoring, quality assurance and control, regulatory submissions, and additional services such as data management, with specialized expertise in orphan disease, pediatric, and medical device trials across Europe, Israel, and Turkey.
Product overview
Siron Clinical is an international contract research organization (CRO) offering a portfolio of clinical trial services ranging from Customizable Functional Service Provider (FSP) to full-service solutions. The core product offering includes six interconnected service modules: Customizable FSP (providing flexible specialist expertise), Project Management, Clinical Monitoring, Quality Assurance and Control, Regulatory Submissions, and Additional Services (including data management). The company specializes in complex clinical trials across orphan diseases, pediatric research, and medical device sectors, supporting biotech companies through Phase I-IV trial delivery across Europe and the Middle East.
Differentiator
Problem solved
Functional benefit
Products and services
- Customizable Functional Service Provider (FSP) Flexible outsourcing model providing specialist expertise and fulfilling specific tasks and functions at every stage of clinical trials, allowing biotech sponsors to scale support as needed across functions such as clinical monitoring, regulatory submissions, and project management.
- Project Management Clinical trial project management and leadership services providing flexibility, innovation, and integrity for successful trial execution for biotech sponsors.
- Clinical Monitoring Expert monitoring support for investigators and study teams providing strategic knowledge, specific guidance, and expertise for study execution across multiple therapeutic areas, delivered by Siron's senior CRAs.
- Quality Assurance and Control Quality assurance and quality control services ensuring accuracy and integrity through continual and dynamic quality processes across clinical trial operations.
- Regulatory Submissions Regulatory submission services with central management of submission processes, handling global regulatory requirements—including the EU Clinical Trials Regulation and CTIS—efficiently and effectively.
- Additional Services (Data Management and Partnerships) Additional CRO services including clinical data management and industry partnerships for international and regional clinical research support.
Quantifiable outcome
- 120+ supported clinical studies over 25 years of operation
- +2 more outcomes
Companies that use Siron Clinical
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles1 record
Siron Clinical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability5 records
Feature2 records
Siron Clinical partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship, core and supporting.
- WEP ClinicalflagshipWEP Clinical, a US-based full-service CRO headquartered in Morrisville, North Carolina, acquired Siron Clinical in January 2026. The acquisition integrates Siron's expertise in orphan diseases, pediatric research, and medical device trials—backed by over 120 supported studies—into WEP's global operations, expanding its Phase I–IV trial delivery capabilities across Europe and the Middle East. Siron continues operating from its current locations in the Netherlands, Belgium, and Germany as part of WEP's Clinical Trials division.
- MontriumcoreSiron Clinical partnered with Montrium in March 2020 to provide clients with access to cutting-edge electronic Trial Master File (eTMF) technology. The partnership enables efficient and effective trial documentation management, improved regulatory compliance, and greater inspection readiness. Montrium is an eTMF provider at the forefront of providing electronic solutions to small and medium-sized companies, offering features including document storage, multi-user access, collaboration tools, and version management.
- Seuss+supportingSiron Clinical partnered with Seuss+, a life-science management consulting company, for its 2020 rebranding from 'Siron' to 'Siron Clinical'. Seuss+ led the brand discovery and creative process, including workshops, visual rebranding, and development of the company's new mission, vision, and values. The rebranding resulted in a new green logo (symbolizing renewal, energy, growth, harmony, and safety) and a modern visual identity reflecting Siron Clinical's DNA.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Siron Clinical competitors and assessment
Company assessmentBroad incumbents
- ICON plc: ICON is a top-3 global CRO offering full-service and FSP engagements across all therapeutic areas and geographies. Broad incumbent competing with Siron for biotech sponsors seeking full-service or large-FSP partnerships.
- IQVIA: IQVIA is the largest global CRO offering full Phase I-IV services, central labs, and real-world evidence. Broad incumbent that competes with Siron for biotech clinical trial work but at vastly larger scale and with broader therapeutic coverage.
Direct peers
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO offering full-service and FSP engagements across multiple therapeutic areas. Comparable to Siron in mid-tier CRO positioning, biotech sponsor focus, and FSP/full-service dual offering.
- Premier Research: Premier Research is a mid-size CRO with explicit specialization in rare disease, oncology, and pediatric trials. Highly comparable to Siron in niche therapeutic focus and biotech sponsor base.
- PSI CRO: PSI is a privately held mid-size CRO with strong European roots serving biotech and pharma sponsors across all phases. Comparable to Siron in CRO scale tier, biotech customer focus, and full-service clinical operations.
- Clinipace Worldwide (now dMed): Clinipace is a mid-size CRO serving small to mid-sized biotech with full-service and FSP offerings. Comparable to Siron in target customer segment, FSP/full-service dual model, and therapeutic breadth.
- Medpace: Medpace is a mid-size, full-service CRO that has scaled by serving small and mid-sized biotech sponsors with a full-service model. Comparable to Siron in target customer (small/mid biotech) and clinical trial service offering, though at much larger scale.
- Atlantic Research Group: Atlantic Research Group is a niche CRO specializing in rare disease, orphan drug, and complex clinical trials. Directly comparable to Siron in rare-disease therapeutic focus and small-biotech customer base.
- Ergomed: Ergomed is a UK-headquartered CRO with a particular focus on orphan and rare disease clinical research. Highly comparable to Siron in therapeutic specialization (rare disease), customer base (small/mid biotech), and European operational footprint.
- Venn Life Sciences: Venn Life Sciences is a European-focused mid-size CRO serving biotech and pharma sponsors. Comparable to Siron in European operational footprint, mid-tier scale, and clinical operations services.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Siron Clinical social profiles
Digital presenceSiron Clinical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Siron Clinical leadership team
Management profileNumber of profiles
Profiles1 record
Siron Clinical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Siron Clinical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Siron Clinical
What does Siron Clinical do?
Siron Clinical is an international contract research organization (CRO) that provides clinical trial services to biotech and biopharma sponsors, including customizable Functional Service Provider (FSP) engagements and full-service CRO contracts. Core offerings cover project management, clinical monitoring, quality assurance and control, regulatory submissions, and additional services such as data management, with specialized expertise in orphan disease, pediatric, and medical device trials across Europe, Israel, and Turkey.
Is Siron Clinical a public or private company?
Siron Clinical is a private company. It is classified as corporate owned and is currently acquired.
When was Siron Clinical founded?
Siron Clinical was founded in 2000. It employs 11 to 50 people.
Where is Siron Clinical based?
Siron Clinical is headquartered in Roosendaal, Netherlands, in the Europe region.
How does Siron Clinical make money?
Two revenue lines are on record. CRO Services – FSP Engagements are the primary driver. The others are CRO Services – Full-Service Contracts.
Who are Siron Clinical's main competitors?
Broad incumbents on record are ICON plc and IQVIA. Direct peers are Worldwide Clinical Trials, Premier Research, PSI CRO, Clinipace Worldwide (now dMed), Medpace, Atlantic Research Group, Ergomed and Venn Life Sciences.
Does Siron Clinical have an API?
No public API is recorded for Siron Clinical.
What industry is Siron Clinical in?
Siron Clinical's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.